Kortekaas J - Search Results

1

Rift Valley fever: biology and epidemiology.

Wright D, Kortekaas J, Bowden TA, Warimwe GM. Wright D, et al. Among authors: kortekaas j. J Gen Virol. 2019 Aug;100(8):1187-1199. doi: 10.1099/jgv.0.001296. Epub 2019 Jul 16. J Gen Virol. 2019. PMID: 31310198 Free PMC article. Review.

2

Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.

de Boer SM, Kortekaas J, Antonis AF, Kant J, van Oploo JL, Rottier PJ, Moormann RJ, Bosch BJ. de Boer SM, et al. Among authors: kortekaas j. Vaccine. 2010 Mar 8;28(11):2330-9. doi: 10.1016/j.vaccine.2009.12.062. Epub 2010 Jan 5. Vaccine. 2010. PMID: 20056185

3

Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus.

Kortekaas J, Dekker A, de Boer SM, Weerdmeester K, Vloet RP, de Wit AA, Peeters BP, Moormann RJ. Kortekaas J, et al. Vaccine. 2010 Mar 8;28(11):2271-6. doi: 10.1016/j.vaccine.2010.01.001. Epub 2010 Jan 14. Vaccine. 2010. PMID: 20079874

4

Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.

Kortekaas J, de Boer SM, Kant J, Vloet RP, Antonis AF, Moormann RJ. Kortekaas J, et al. Vaccine. 2010 Jun 17;28(27):4394-401. doi: 10.1016/j.vaccine.2010.04.048. Epub 2010 Apr 29. Vaccine. 2010. PMID: 20434545

5

Interventions against West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus: where are we?

Kortekaas J, Ergönül O, Moormann RJ. Kortekaas J, et al. Vector Borne Zoonotic Dis. 2010 Oct;10(7):709-18. doi: 10.1089/vbz.2010.0040. Vector Borne Zoonotic Dis. 2010. PMID: 20854026

6

Rift Valley Fever Vaccine Development, Progress and Constraints.

Kortekaas J, Zingeser J, de Leeuw P, de La Rocque S, Unger H, Moormann RJ. Kortekaas J, et al. Emerg Infect Dis. 2011 Sep;17(9):e1. doi: 10.3201/eid1709.110506. Emerg Infect Dis. 2011. PMID: 21888781 Free PMC article. No abstract available.

7

Creation of a nonspreading Rift Valley fever virus.

Kortekaas J, Oreshkova N, Cobos-Jiménez V, Vloet RP, Potgieter CA, Moormann RJ. Kortekaas J, et al. J Virol. 2011 Dec;85(23):12622-30. doi: 10.1128/JVI.00841-11. Epub 2011 Sep 28. J Virol. 2011. PMID: 21957302 Free PMC article.

8

Efficacy of three candidate Rift Valley fever vaccines in sheep.

Kortekaas J, Antonis AF, Kant J, Vloet RP, Vogel A, Oreshkova N, de Boer SM, Bosch BJ, Moormann RJ. Kortekaas J, et al. Vaccine. 2012 May 14;30(23):3423-9. doi: 10.1016/j.vaccine.2012.03.027. Epub 2012 Mar 24. Vaccine. 2012. PMID: 22449427

9

Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein.

van der Wal FJ, Achterberg RP, de Boer SM, Boshra H, Brun A, Maassen CB, Kortekaas J. van der Wal FJ, et al. Among authors: kortekaas j. J Virol Methods. 2012 Aug;183(2):99-105. doi: 10.1016/j.jviromet.2012.03.008. Epub 2012 Mar 16. J Virol Methods. 2012. PMID: 22449758

10

Heparan sulfate facilitates Rift Valley fever virus entry into the cell.

de Boer SM, Kortekaas J, de Haan CA, Rottier PJ, Moormann RJ, Bosch BJ. de Boer SM, et al. Among authors: kortekaas j. J Virol. 2012 Dec;86(24):13767-71. doi: 10.1128/JVI.01364-12. Epub 2012 Sep 26. J Virol. 2012. PMID: 23015725 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters